FDA crackdown intensifies, Mumbai’s famous Ayub’s latest on list
We haven't written up this one. The Indian Express has the full story — the link below goes straight to it.
More in Health & Medicine
U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
Ziihera plus tislelizumab and chemotherapy approved for first-line treatment of all HER2+ GEA patients (IHC 3+ and IHC 2+/ISH+) regardless of PD-L1 status, providing a new treatment option in…
FDA Clears Blood Test to Detect Alzheimer's in Primary and Specialty Care
(MedPage Today) -- The FDA cleared the Elecsys pTau217 blood test to identify amyloid-beta pathology associated with Alzheimer's disease in people ages 55 and older with symptoms of cognitive decline…
ARCH and Population Health join China blitz with Haisco deal
China-based drugmaker Haisco Pharmaceutical has been on a dealmaking tear this summer, and its latest alliance is with two dominant names in biotech.
‘I carried used condom from home’: Medic accused of raping dialysis patient acquitted
Wabwile was accused of unlawfully penetrating the adult patient, identified in the judgment as M.T.K., at Pandya Memorial Hospital.
No need for masks as H1N1 drives seasonal flu surge, says ICMR chief
With 99% of cases remaining mild, ICMR advises basic hygiene over masks and recommends flu shots only for high-risk individuals.
GROUNDUP: World’s largest biomedical research funder lifts ban on South Africa
Many clinical trials were halted and many researchers were retrenched when the US National Institutes of Health stopped funding.